Law360, New York (November 9, 2011, 4:56 PM EST) -- The state of Oregon on Monday sued McKesson Corp. in California federal court, claiming the drug distributor conspired to artificially inflate average wholesale drug prices, costing taxpayers millions in higher Medicaid reimbursements. Oregon claims McKesson, the nation's largest pharmaceutical wholesaler, unlawfully inflated the published average wholesale prices for hundreds of brand name drugs — including Advair, Allegra, Celebrex, Flonase, Lipitor and Zyprexa. The state says the price inflation scheme devised by McKesson and drug price publisher First DataBank Inc. caused pharmacies and other providers to submit fraudulent, inflated claims to Oregon Medicaid from 2001 to September 2009. “The submission of each...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)

Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.

Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS